Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information
- PMID: 23123013
- DOI: 10.1016/j.virol.2012.10.003
Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information
Abstract
Multiple organisms face the threat of viral infections. To combat phage invasion, bacteria and archaea have evolved an adaptive mechanism of protection against exogenic mobile genetic elements, called CRISPR-Cas. In this defense strategy, phage infection is memorized via acquisition of a short invader sequence, called a spacer, into the CRISPR locus of the host genome. Upon repeated infection, the 'vaccinated' host expresses the spacer as a precursor RNA, which is processed into a mature CRISPR RNA (crRNA) that guides an endonuclease to the matching invader for its ultimate destruction. Recent efforts have uncovered molecular details underlying the crRNA biogenesis and interference steps. However, until recently the step of adaptation had remained largely uninvestigated. In this minireview, we focus on recent publications that have begun to reveal molecular insights into the adaptive step of CRISPR-Cas immunity, which is required for the development of the heritable memory of the host against viruses.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
CRISPR-Cas systems and RNA-guided interference.Wiley Interdiscip Rev RNA. 2013 May-Jun;4(3):267-78. doi: 10.1002/wrna.1159. Epub 2013 Mar 20. Wiley Interdiscip Rev RNA. 2013. PMID: 23520078 Review.
-
Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes.Biol Chem. 2011 Apr;392(4):277-89. doi: 10.1515/BC.2011.042. Epub 2011 Feb 7. Biol Chem. 2011. PMID: 21294681 Review.
-
Viral diversity threshold for adaptive immunity in prokaryotes.mBio. 2012 Dec 4;3(6):e00456-12. doi: 10.1128/mBio.00456-12. mBio. 2012. PMID: 23221803 Free PMC article.
-
CRISPR/Cas, the immune system of bacteria and archaea.Science. 2010 Jan 8;327(5962):167-70. doi: 10.1126/science.1179555. Science. 2010. PMID: 20056882 Review.
-
CRISPR/Cas and Cmr modules, mobility and evolution of adaptive immune systems.Res Microbiol. 2011 Jan;162(1):27-38. doi: 10.1016/j.resmic.2010.09.001. Epub 2010 Sep 21. Res Microbiol. 2011. PMID: 20863886
Cited by
-
In vivo gene delivery mediated by non-viral vectors for cancer therapy.J Control Release. 2020 Sep 10;325:249-275. doi: 10.1016/j.jconrel.2020.06.038. Epub 2020 Jul 4. J Control Release. 2020. PMID: 32634464 Free PMC article. Review.
-
RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes.J Hematol Oncol. 2015 Apr 2;8:31. doi: 10.1186/s13045-015-0127-3. J Hematol Oncol. 2015. PMID: 25888285 Free PMC article. Review.
-
A PNPase dependent CRISPR System in Listeria.PLoS Genet. 2014 Jan;10(1):e1004065. doi: 10.1371/journal.pgen.1004065. Epub 2014 Jan 9. PLoS Genet. 2014. PMID: 24415952 Free PMC article.
-
Diversity of CRISPR-Cas immune systems and molecular machines.Genome Biol. 2015 Nov 9;16:247. doi: 10.1186/s13059-015-0816-9. Genome Biol. 2015. PMID: 26549499 Free PMC article. Review.
-
Genome-editing Technologies for Gene and Cell Therapy.Mol Ther. 2016 Mar;24(3):430-46. doi: 10.1038/mt.2016.10. Epub 2016 Jan 12. Mol Ther. 2016. PMID: 26755333 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources